CoyDonHeldermonMD

Breast Cancer, Hematologic Oncology

Specialty in breast cancer treatment and lysosomal storage diseases

Dr. Heldermon is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
1600 SW Archer Road
PO Box 100278
Gainesville, FL 32610
Phone+1 352-273-7497

Fax+1 352-273-2078

Washington University/B-JH/SLCH ConsortiumFellowship, Hematology and Medical Oncology, 2004 - 2008
Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 2002 - 2004
Stanford Health Care-Sponsored Stanford UniversityInternship, Internal Medicine, 2001 - 2002
University of Oklahoma College of MedicineClass of 2001

PubMed

8 citations
LC-MS Lipidomics of Renal Biopsies for the Diagnosis of Fabry Disease
Hoda Safari Yazd, Sina Feizbakhsh Bazargani, Christine A. Vanbeek, Kelli King-Morris, Coy D. Heldermon
Journal of Mass Spectrometry and Advances in the Clinical Lab. 2021-11-26
19 citations
Novel agents that downregulate EGFR, HER2, and HER3 in parallel
Renan B. Ferreira, Mary Elizabeth Law, Stephan C. Jahn, Bradley J. Davis, Coy D. Heldermon
Oncotarget. 2015-03-21
14 citations
Preferred transduction with AAV8 and AAV9 via thalamic administration in the MPS IIIB model: A comparison of four rAAV serotypes.
Janine Gilkes, Matthew Bloom, Coy D. Heldermon
Molecular Genetics and Metabolism Reports. 2016-03-01